Filing Details

Accession Number:
0001493152-23-025185
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-21 10:06:58
Reporting Period:
2023-07-20
Accepted Time:
2023-07-21 10:06:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
715446 Anixa Biosciences Inc ANIX Pharmaceutical Preparations (2834) 112622630
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1689394 Michael Catelani C/O Anixa Biosciences, Inc.
3150 Almaden Expressway, Suite 250
San Jose, CA 95118
President, Coo & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-07-20 5,500 $3.64 26,655 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct